24th Schrödinger European User Group Meeting

We are proud to participate in and present at the 24th Schrödinger European User Group Meeting – a premier annual event for knowledge exchange and innovation across the life sciences ecosystem.

Schrödinger’s physics-based computational platform is trusted by the world’s leading pharma and biotech companies. Evogene is a proud long-standing user of this molecular simulation technology, which is integrated into our ChemPass AI™ engine for small-molecule discovery and optimization.

Dr. Roberto Olender, Head of Algorithms at Evogene, will present advanced computational approaches for novel molecule design.

Session Details:
Track: Small Molecules
Session: Project Advancements Through Custom Computational Models

• Small Molecule Drug Design Supported by Generative Artificial Intelligence Technologies | Christoph Grebner, Sanofi
• Multi-Objective GenAI Foundation Model for De Novo Design of Molecules | Dr. Roberto Olender, Evogene

Date & Time: May 20, 2026 | 11:00 AM – 12:30 PM CEST

Dr. Gabi Tacic CDO, Dr. Hamutal Engel, Head of Development and Dr. Nikolay Kuzmich, Computer-Aided Drug Design Researcher at Evogene, will also be attending and available for meetings. We welcome the opportunity to connect with collaborators, researchers, and industry partners to explore new avenues for advancing innovation in drug discovery. Please DM to schedule an onsite meeting.

For more details, visit the official event page:
https://www.schrodinger.com/life-science/resources/event/24th-schrodinger-european-user-group-meeting/